Epithelial Ovarian Cancer: A Five Year Review.
Christos ArnaoutoglouKalliopi DampalaChristos AnthoulakisEvangelos G PapanikolaouIoannis TentasGeorgios DragoutsosNikolaos ThomakosPavlos ZarogoulidisAristeidis IoannidisDimitris MatthaiosEleni I PerdikouriDimitirios GiannakidisChrisanthi SardeliStamatios PetousisPanagoula OikonomouChristina NikolaouCharalampos CharalampidisKonstantinos SapalidisPublished in: Medicina (Kaunas, Lithuania) (2023)
Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment combinations for advanced stage cancer. Several novel therapies are currently being investigated, with gene therapy and stem cell therapy being the corner stone of this investigation. We conducted a thorough search on PubMed and gathered up-to-date information regarding epithelial ovarian cancer therapies. We present, in the current review, all novel treatments that were investigated in this field over the past five years, with a particular focus on local treatment.
Keyphrases
- cell therapy
- early stage
- gene therapy
- papillary thyroid
- end stage renal disease
- chronic kidney disease
- ejection fraction
- stem cells
- squamous cell
- mesenchymal stem cells
- healthcare
- squamous cell carcinoma
- peritoneal dialysis
- atomic force microscopy
- combination therapy
- young adults
- locally advanced
- sentinel lymph node